9 mg Budesonide Once Daily (OD) Versus 3 mg Budesonide Three Times Daily (TID) in Active Crohn's Disease
Status:
Completed
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
This study aims to evaluate the efficacy of 9 mg budesonide once daily (OD) versus 3 mg
budesonide three-times daily (TID) for the induction of remission in Crohn's disease.